HLB PHARMACEUTICAL CO., LTD. 047920
KRX · South Korea · Health Technology
KRW 10,260.00-890.00 (-7.98%)
Market open· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
As global markets experience a positive shift with de-escalating Middle East tensions and robust economic indicators, Asia's stock landscape presents unique opportunities for discovery. In this dynamic environment, identifying stocks that show resilience and potential growth amidst these broader market trends can be crucial for investors seeking to uncover hidden gems in the region.
Amidst the backdrop of geopolitical tensions and fluctuating energy prices, Asian markets have been navigating a complex landscape, with investor sentiment reflecting both caution and opportunity. As key indices like the S&P MidCap 400 show signs of resilience by snapping recent losing streaks, small-cap stocks in Asia may present unique opportunities for investors seeking to explore under-the-radar companies that could thrive despite broader market uncertainties. Identifying promising stocks...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.